Welcome • User Guide
ToS • Privacy • Canary
Donate • Bugs • License

©2025 Poal.co

282
  • The RSV vaccine was 83.7% effective at preventing lower respiratory tract disease, defined as two or more symptoms, in people ages 60 and older, according to Moderna.
  • RSV infections kill between 6,000 and 10,000 older adults every year and result in 60,000 to 120,000 hospitalizations, according to the CDC.
  • Moderna’s RSV vaccine uses the same messenger RNA technology as its successful Covid-19 shots.
>- The RSV vaccine was 83.7% effective at preventing lower respiratory tract disease, defined as two or more symptoms, in people ages 60 and older, according to Moderna. - RSV infections kill between 6,000 and 10,000 older adults every year and result in 60,000 to 120,000 hospitalizations, according to the CDC. - Moderna’s RSV vaccine uses the same messenger RNA technology as its **successful Covid-19 shots**.

(post is archived)

You are currently inside a comment thread.
Click here to see all the comments (6).
[–] • 0 pt

They are different strains of viruses and the mRNA is [supposedly] designed for one strain per vaxx type.

[–] • 0 pt

I read it wrong, I thought they were claiming the spike jab was 87% effective against RSV.